SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-024982
Filing Date
2019-04-17
Accepted
2019-04-17 16:24:08
Documents
1
Period of Report
2019-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4023
  Complete submission text file 0001209191-19-024982.txt   5393
Mailing Address 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121 (858) 412-8400
Tocagen Inc (Issuer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TOCAGEN INC. 4242 CAMPUS POINT COURT, STE. 500 SAN DIEGO CA 92121
Business Address
Kabbinavar Fairooz (Reporting) CIK: 0001774182 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38052 | Film No.: 19753276